[EN] COMPOUNDS USEFUL AS INHIBITORS OF CHOLINE KINASE<br/>[FR] COMPOSÉS UTILES EN TANT QU'INHIBITEURS DE LA CHOLINE KINASE
申请人:VERTEX PHARMA
公开号:WO2013043960A1
公开(公告)日:2013-03-28
The present invention relates to compounds useful as inhibitors of choline kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Oxadiazoles useful in the treatment of senile dementia
申请人:Merck, Sharp & Dohme, Ltd.
公开号:US05686463A1
公开(公告)日:1997-11-11
A class of novel oxadiazoles, substituted on one of the ring carbon atoms with a non-aromatic azacyclic or azabicyclic ring, and substituted on the other ring carbon atom with a substituent of low lipophilicity; are potent muscarinic agonists, and have good CNS penetrability. The compounds are therefore useful in the treatment of neurological and mental illnesses.
FUSED HETEROCYCLIC COMPOUND AND MEDICINAL USE THEREOF
申请人:Mitsubishi Pharma Corporation
公开号:EP1396488A1
公开(公告)日:2004-03-10
The fused heterocyclic compound of the present invention, which is represented by the formula (I):
wherein each symbol is as defined in the specification, an optically active form thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a water adduct thereof show poly(ADP-ribose) synthase inhibitory action and are useful as therapeutic drugs for cerebral infarction.
Synthesis and in vitro muscarinic activities of a series of 3-(pyrazol-3-yl)-1-azabicyclo[2.2.2]octanes
作者:Ralf Plate、Marc J.M. Plaum、Rob G.A.v.d. Hulst、Thijs de Boer
DOI:10.1016/s0968-0896(99)00299-0
日期:2000.2
A series of 3-(pyrazol-3-yl)-1-azabicyclo[2.2.2]octane derivatives C (Fig. 1) was synthesized and tested for muscarinic activity in receptor binding assays using [3H]-oxotremorine-M (OXO-M) and [3H]-pirenzepine (PZ) as ligands. Potential muscarinic agonistic or antagonistic properties of the compounds were determined using binding studies measuring their potencies to inhibit the binding of OXO-M and
Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives
作者:Harry J. Wadsworth、Sarah M. Jenkins、Barry S. Orlek、Frederick Cassidy、Michael S. G. Clark、Frank Brown、Graham J. Riley、Diane Graves、Julie Hawkins、Christopher B. Naylor
DOI:10.1021/jm00085a016
日期:1992.4
The synthesis of 15 methyl or unsubstituted 1,2,3-triazoles, 1,2,4-triazoles, and tetrazoles additionally substituted with a 1-azabicyclo[2.2.2]octan-3-yl group is described. The potency and efficacy of these compounds as muscarinic ligands were determined in radioligand binding assays using [3H]oxotremorine and [3H]quinuclidinyl benzilate. Potency and efficacy were found in compounds in which the